ArticleOPEN ACCESS

Epigenetic priming: The target?

Blood
DOI: 10.1182/blood-2011-06-357533
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Despite major advances made over the past 2 decades in our understanding of underlying disease mechanisms, prognostication, risk-adapted treatment stratification, and patient care, clinical outcomes in AML(acute myeloid leukemia) remain overall poor.

Cite

CITATION STYLE

APA

Mims, A., & Marcucci, G. (2011, August 11). Epigenetic priming: The target? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-06-357533

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free